What’s New at NIDA
NIDA Inviting Input on Racial Equity Initiative Action Plan
The National Institute on Drug Abuse (NIDA) invites your feedback on the draft NIDA Racial Equity Initiative Action Plan. Our ongoing Racial Equity Initiative has been spearheading the Institute’s efforts to address the impact of structural racism on addiction science and to take action to promote racial equity in NIDA’s workplace, workforce, and research portfolio.
Your comments are welcome on all areas of the plan. Please also feel free to share the Request for Information (RFI) widely to encourage as broad a response as possible. Responses are due by May 31, 2022.
Action plan and instructions for submitting feedback.
See Dr. Nora Volkow's blog, A Plan to Address Racism in Addiction Science for more information.
Help NIDA spread the word:
We look forward to hearing from you!
NIDA Diversity Scholars Travel Award Program
The National Institute on Drug Abuse (NIDA), Office of Diversity and Health Disparities (ODHD) is accepting applications for the NIDA Diversity Scholars Travel Award Program to help defray the costs of attending national scientific conferences. Please see the below application for more information and consider sharing with anyone who may be interested. Scientists from underrepresented backgrounds are encouraged to apply, though individuals from all backgrounds are eligible to participate.
Apply for a travel award to any of the below scientific conferences:
- The American Psychological Association (APA) on August 4th – 6th, 2022 in Minneapolis, MN
- The National Hispanic Science Network International Conference (NHSN) on September 28th – 30th, 2022 in Grand Rapids, MI
- The Annual Society for Neuroscience (SfN) Meeting on November 12th – 16th, 2022 in San Diego, CA
Please reach out to Isabela Lopes (Isabela.Lopes@nih.gov) if you have any questions.
NIDA Diversity Scholars Travel Award Program application
NIDA INVEST Postdoctoral Fellowship for International Scholars – Now Accepting Applications
NIDA International Program is accepting applications for International Postdoctoral researchers for the INVEST Drug Abuse Research Fellowship. This combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug abuse scientists.
Fellowship: The 12-month fellowship provides rigorous postdoctoral research training with a NIDA grantee at a U.S. institution. Professional development activities that help establish personal relationships with NIDA grantees and NIDA officials. A stipend for living and personal expenses, and an allowance to cover the cost of health insurance and professional development activities. Applications are due July 1st and October 1st.
Eligibility: International researchers with a doctoral degree and a minimum of 2 years postdoctoral experience. Citizenship or permanent residency in a country other than the United States. Proficiency in written and spoken English is also required
INVEST Mentors: Mentors must be a NIDA-funded researcher in the United States. The mentor’s NIDA-funded grant must be active throughout the proposed fellowship period.
Reference: Steven W. Gust, Judy McCormally & Nei-Hyun Park (2021) Increasing evidence-based substance use interventions globally: The National Institute on Drug Abuse postdoctoral fellowships, Substance Abuse, 42:4, 397-406, DOI: 10.1080/08897077.2021.1975874
Contact NIDA: For questions about the INVEST Postdoctoral Fellowship (including the application and review process, or selecting a mentor) contactip@nida.nih.gov
Congratulations to NIDA Kirschstein-NRSA (T32) Awardees in Fiscal Year 2021!
We would like to congratulate the awardees of NIDA NRSA (T32) awards in Fiscal Year 2021! The goal of the Kirschstein-NRSA training program is to prepare qualified predoctoral and/or postdoctoral trainees for careers that have a significant impact on the health-related research needs of the Nation.
Full list of active NIDA T32 grantees from NIH RePORTER.
Don’t forget! New funding opportunities are released on a continuous basis. For more information on NIDA Funding Opportunities, visit the Funding Opportunities at NIDA webpage. For a full list of NIH training, fellowship, career development, and research education funding opportunities including parent announcements, please visit and subscribe to the NIH Guide to Grants and Funding.
Program Updates
Apply for a NIDA Diversity Supplement before the deadline on May 06, 2022!
Calling all NIDA researchers and trainees! The NIDA Diversity Supplement Program continues to accept applications to support post-baccalaureates, pre-doctoral students, post-doctorates, and early-stage investigator training. This program provides support for underrepresented scientists at these career stages to prepare for an independent career in addiction research. We are looking to increase the number of NIDA Diversity Supplement post-doctorates and early-stage investigators scholars so please spread the word! Please apply to the diversity supplement FOA, PA-21-071.
There are multiple Diversity Supplement Programs to consider. Grants supported under the NIH Helping End Addiction Long-term (HEAL) initiatives, grants supported under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) program, and the existing NIDA grant programs are all offering Diversity Supplements to provide support that will help launch the careers of underrepresented scientists in addiction research. HEAL awardees must apply to PA-21-071 through the NOSI, NOT-NS-20-107. BRAIN Initiative awardees must apply to PA-21-071 through the NOSI, NOT-NS-22-012.
PIs with HIV/AIDS-related grants are particularly encouraged to apply as well as PIs who are part of the CTN. Application Deadline for FY2022: May 06, 2022.
For more information on the NIDA Diversity Supplement Program please see the NIDA Diversity Supplement Program webpage, FAQs, and How to Apply.
Did You Know?
Upcoming Symposium with Avant-Garde Awardees: Join NIDA’s HIV Research Program for a virtual symposium with past Avant-Garde Awardee recipients on May 18, 2022. The NIDA Avant-Garde Award Program supports individual scientists of exceptional creativity at all career levels who propose high-impact research that will open new areas of HIV research and/or lead to new avenues for prevention and treatment of HIV among people who use drugs. The term “avant-garde” is used to describe highly innovative approaches that have the potential to be transformative. Past awardees will discuss their projects and will answer questions about being on the cutting edge of HIV research.
2022 NIDA HRP Avant-Garde Symposium Announcement
NIH Grants YouTube Channel
The NIH has a YouTube channel with videos that contain helpful information about applying for NIH grants! The most recent video includes a tutorial on how to electronically submit an ESI status extension request directly from eRA Commons to the extension committee. Visit the NIH Grants channel and see other related videos.
Stay Up to Date!
Interested in upcoming NIDA meetings and events? See a full list of what’s coming up. Visit the Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding webpage for the latest information and guidance about programs in place to help with NIH projects. This webpage provides information about proposal submission, award management, human subjects, clinical trials, animal welfare, peer review, and lists funding opportunities related specifically to COVID-19. We encourage you to check this webpage often for updates and don’t hesitate to reach out to your Program Officer or our office if you have questions.